1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global LFA-based Cardiac Marker Market Size Growth Rate by Type: 2016 VS 2021 VS 2027 1.2.2 Troponin 1.2.3 CK-MB 1.2.4 Myoglobin 1.2.5 Others 1.3 Market by Application 1.3.1 Global LFA-based Cardiac Marker Market Share by Application: 2016 VS 2021 VS 2027 1.3.2 Laboratory Testing 1.3.3 Point-of-care Testing 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global LFA-based Cardiac Marker Market Perspective (2016-2027) 2.2 LFA-based Cardiac Marker Growth Trends by Regions 2.2.1 LFA-based Cardiac Marker Market Size by Regions: 2016 VS 2021 VS 2027 2.2.2 LFA-based Cardiac Marker Historic Market Share by Regions (2016-2021) 2.2.3 LFA-based Cardiac Marker Forecasted Market Size by Regions (2022-2027) 2.3 LFA-based Cardiac Marker Industry Dynamic 2.3.1 LFA-based Cardiac Marker Market Trends 2.3.2 LFA-based Cardiac Marker Market Drivers 2.3.3 LFA-based Cardiac Marker Market Challenges 2.3.4 LFA-based Cardiac Marker Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top LFA-based Cardiac Marker Players by Revenue 3.1.1 Global Top LFA-based Cardiac Marker Players by Revenue (2016-2021) 3.1.2 Global LFA-based Cardiac Marker Revenue Market Share by Players (2016-2021) 3.2 Global LFA-based Cardiac Marker Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by LFA-based Cardiac Marker Revenue 3.4 Global LFA-based Cardiac Marker Market Concentration Ratio 3.4.1 Global LFA-based Cardiac Marker Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by LFA-based Cardiac Marker Revenue in 2020 3.5 LFA-based Cardiac Marker Key Players Head office and Area Served 3.6 Key Players LFA-based Cardiac Marker Product Solution and Service 3.7 Date of Enter into LFA-based Cardiac Marker Market 3.8 Mergers & Acquisitions, Expansion Plans 4 LFA-based Cardiac Marker Breakdown Data by Type 4.1 Global LFA-based Cardiac Marker Historic Market Size by Type (2016-2021) 4.2 Global LFA-based Cardiac Marker Forecasted Market Size by Type (2022-2027) 5 LFA-based Cardiac Marker Breakdown Data by Application 5.1 Global LFA-based Cardiac Marker Historic Market Size by Application (2016-2021) 5.2 Global LFA-based Cardiac Marker Forecasted Market Size by Application (2022-2027) 6 North America 6.1 North America LFA-based Cardiac Marker Market Size (2016-2027) 6.2 North America LFA-based Cardiac Marker Market Size by Type 6.2.1 North America LFA-based Cardiac Marker Market Size by Type (2016-2021) 6.2.2 North America LFA-based Cardiac Marker Market Size by Type (2022-2027) 6.2.3 North America LFA-based Cardiac Marker Market Size by Type (2016-2027) 6.3 North America LFA-based Cardiac Marker Market Size by Application 6.3.1 North America LFA-based Cardiac Marker Market Size by Application (2016-2021) 6.3.2 North America LFA-based Cardiac Marker Market Size by Application (2022-2027) 6.3.3 North America LFA-based Cardiac Marker Market Size by Application (2016-2027) 6.4 North America LFA-based Cardiac Marker Market Size by Country 6.4.1 North America LFA-based Cardiac Marker Market Size by Country (2016-2021) 6.4.2 North America LFA-based Cardiac Marker Market Size by Country (2022-2027) 6.4.3 United States 6.4.4 Canada 7 Europe 7.1 Europe LFA-based Cardiac Marker Market Size (2016-2027) 7.2 Europe LFA-based Cardiac Marker Market Size by Type 7.2.1 Europe LFA-based Cardiac Marker Market Size by Type (2016-2021) 7.2.2 Europe LFA-based Cardiac Marker Market Size by Type (2022-2027) 7.2.3 Europe LFA-based Cardiac Marker Market Size by Type (2016-2027) 7.3 Europe LFA-based Cardiac Marker Market Size by Application 7.3.1 Europe LFA-based Cardiac Marker Market Size by Application (2016-2021) 7.3.2 Europe LFA-based Cardiac Marker Market Size by Application (2022-2027) 7.3.3 Europe LFA-based Cardiac Marker Market Size by Application (2016-2027) 7.4 Europe LFA-based Cardiac Marker Market Size by Country 7.4.1 Europe LFA-based Cardiac Marker Market Size by Country (2016-2021) 7.4.2 Europe LFA-based Cardiac Marker Market Size by Country (2022-2027) 7.4.3 Germany 7.4.4 France 7.4.5 U.K. 7.4.6 Italy 7.4.7 Russia 7.4.8 Nordic 8 Asia-Pacific 8.1 Asia-Pacific LFA-based Cardiac Marker Market Size (2016-2027) 8.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type 8.2.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2021) 8.2.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2022-2027) 8.2.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2027) 8.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Application 8.3.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2021) 8.3.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2022-2027) 8.3.3 Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2027) 8.4 Asia-Pacific LFA-based Cardiac Marker Market Size by Region 8.4.1 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2016-2021) 8.4.2 Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2022-2027) 8.4.3 China 8.4.4 Japan 8.4.5 South Korea 8.4.6 Southeast Asia 8.4.7 India 8.4.8 Australia 9 Latin America 9.1 Latin America LFA-based Cardiac Marker Market Size (2016-2027) 9.2 Latin America LFA-based Cardiac Marker Market Size by Type 9.2.1 Latin America LFA-based Cardiac Marker Market Size by Type (2016-2021) 9.2.2 Latin America LFA-based Cardiac Marker Market Size by Type (2022-2027) 9.2.3 Latin America LFA-based Cardiac Marker Market Size by Type (2016-2027) 9.3 Latin America LFA-based Cardiac Marker Market Size by Application 9.3.1 Latin America LFA-based Cardiac Marker Market Size by Application (2016-2021) 9.3.2 Latin America LFA-based Cardiac Marker Market Size by Application (2022-2027) 9.3.3 Latin America LFA-based Cardiac Marker Market Size by Application (2016-2027) 9.4 Latin America LFA-based Cardiac Marker Market Size by Country 9.4.1 Latin America LFA-based Cardiac Marker Market Size by Country (2016-2021) 9.4.2 Latin America LFA-based Cardiac Marker Market Size by Country (2022-2027) 9.4.3 Mexico 9.4.4 Brazil 10 Middle East & Africa 10.1 Middle East & Africa LFA-based Cardiac Marker Market Size (2016-2027) 10.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type 10.2.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2021) 10.2.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2022-2027) 10.2.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2027) 10.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Application 10.3.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2021) 10.3.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2022-2027) 10.3.3 Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2027) 10.4 Middle East & Africa LFA-based Cardiac Marker Market Size by Country 10.4.1 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2016-2021) 10.4.2 Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2022-2027) 10.4.3 Turkey 10.4.4 Saudi Arabia 10.4.5 UAE 11 Key Players Profiles 11.1 Thermo Fisher 11.1.1 Thermo Fisher Company Details 11.1.2 Thermo Fisher Business Overview 11.1.3 Thermo Fisher LFA-based Cardiac Marker Introduction 11.1.4 Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.1.5 Thermo Fisher Recent Development 11.2 Bio-Rad Laboratories 11.2.1 Bio-Rad Laboratories Company Details 11.2.2 Bio-Rad Laboratories Business Overview 11.2.3 Bio-Rad Laboratories LFA-based Cardiac Marker Introduction 11.2.4 Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.2.5 Bio-Rad Laboratories Recent Development 11.3 Becton, Dickinson 11.3.1 Becton, Dickinson Company Details 11.3.2 Becton, Dickinson Business Overview 11.3.3 Becton, Dickinson LFA-based Cardiac Marker Introduction 11.3.4 Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.3.5 Becton, Dickinson Recent Development 11.4 Roche 11.4.1 Roche Company Details 11.4.2 Roche Business Overview 11.4.3 Roche LFA-based Cardiac Marker Introduction 11.4.4 Roche Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.4.5 Roche Recent Development 11.5 Hologic 11.5.1 Hologic Company Details 11.5.2 Hologic Business Overview 11.5.3 Hologic LFA-based Cardiac Marker Introduction 11.5.4 Hologic Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.5.5 Hologic Recent Development 11.6 Abbott 11.6.1 Abbott Company Details 11.6.2 Abbott Business Overview 11.6.3 Abbott LFA-based Cardiac Marker Introduction 11.6.4 Abbott Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.6.5 Abbott Recent Development 11.7 Siemens 11.7.1 Siemens Company Details 11.7.2 Siemens Business Overview 11.7.3 Siemens LFA-based Cardiac Marker Introduction 11.7.4 Siemens Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.7.5 Siemens Recent Development 11.8 Danaher 11.8.1 Danaher Company Details 11.8.2 Danaher Business Overview 11.8.3 Danaher LFA-based Cardiac Marker Introduction 11.8.4 Danaher Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.8.5 Danaher Recent Development 11.9 Alere 11.9.1 Alere Company Details 11.9.2 Alere Business Overview 11.9.3 Alere LFA-based Cardiac Marker Introduction 11.9.4 Alere Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.9.5 Alere Recent Development 11.10 BioMérieux 11.10.1 BioMérieux Company Details 11.10.2 BioMérieux Business Overview 11.10.3 BioMérieux LFA-based Cardiac Marker Introduction 11.10.4 BioMérieux Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.10.5 BioMérieux Recent Development 11.11 LSI 11.11.1 LSI Company Details 11.11.2 LSI Business Overview 11.11.3 LSI LFA-based Cardiac Marker Introduction 11.11.4 LSI Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.11.5 LSI Recent Development 11.12 Clinical Diagnostics 11.12.1 Clinical Diagnostics Company Details 11.12.2 Clinical Diagnostics Business Overview 11.12.3 Clinical Diagnostics LFA-based Cardiac Marker Introduction 11.12.4 Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.12.5 Clinical Diagnostics Recent Development 11.13 Randox laboratories 11.13.1 Randox laboratories Company Details 11.13.2 Randox laboratories Business Overview 11.13.3 Randox laboratories LFA-based Cardiac Marker Introduction 11.13.4 Randox laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.13.5 Randox laboratories Recent Development 11.14 Wondfo Biotech 11.14.1 Wondfo Biotech Company Details 11.14.2 Wondfo Biotech Business Overview 11.14.3 Wondfo Biotech LFA-based Cardiac Marker Introduction 11.14.4 Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2016-2021) 11.14.5 Wondfo Biotech Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global LFA-based Cardiac Marker Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027 Table 2. Key Players of Troponin Table 3. Key Players of CK-MB Table 4. Key Players of Myoglobin Table 5. Key Players of Others Table 6. Global LFA-based Cardiac Marker Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027 Table 7. Global LFA-based Cardiac Marker Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027 Table 8. Global LFA-based Cardiac Marker Market Size by Regions (2016-2021) & (US$ Million) Table 9. Global LFA-based Cardiac Marker Market Share by Regions (2016-2021) Table 10. Global LFA-based Cardiac Marker Forecasted Market Size by Regions (2022-2027) & (US$ Million) Table 11. Global LFA-based Cardiac Marker Market Share by Regions (2022-2027) Table 12. LFA-based Cardiac Marker Market Trends Table 13. LFA-based Cardiac Marker Market Drivers Table 14. LFA-based Cardiac Marker Market Challenges Table 15. LFA-based Cardiac Marker Market Restraints Table 16. Global LFA-based Cardiac Marker Revenue by Players (2016-2021) & (US$ Million) Table 17. Global LFA-based Cardiac Marker Market Share by Players (2016-2021) Table 18. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LFA-based Cardiac Marker as of 2020) Table 19. Ranking of Global Top LFA-based Cardiac Marker Companies by Revenue (US$ Million) in 2020 Table 20. Global 5 Largest Players Market Share by LFA-based Cardiac Marker Revenue (CR5 and HHI) & (2016-2021) Table 21. Key Players Headquarters and Area Served Table 22. Key Players LFA-based Cardiac Marker Product Solution and Service Table 23. Date of Enter into LFA-based Cardiac Marker Market Table 24. Mergers & Acquisitions, Expansion Plans Table 25. Global LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 26. Global LFA-based Cardiac Marker Revenue Market Share by Type (2016-2021) Table 27. Global LFA-based Cardiac Marker Forecasted Market Size by Type (2022-2027) (US$ Million) Table 28. Global LFA-based Cardiac Marker Revenue Market Share by Type (2022-2027) & (US$ Million) Table 29. Global LFA-based Cardiac Marker Market Size Share by Application (2016-2021) & (US$ Million) Table 30. Global LFA-based Cardiac Marker Revenue Market Share by Application (2016-2021) Table 31. Global LFA-based Cardiac Marker Forecasted Market Size by Application (2022-2027) (US$ Million) Table 32. Global LFA-based Cardiac Marker Revenue Market Share by Application (2022-2027) & (US$ Million) Table 33. North America LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 34. North America LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million) Table 35. North America LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million) Table 36. North America LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million) Table 37. North America LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million) Table 38. North America LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million) Table 39. Europe LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 40. Europe LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million) Table 41. Europe LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million) Table 42. Europe LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million) Table 43. Europe LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million) Table 44. Europe LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million) Table 45. Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 46. Asia-Pacific LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million) Table 47. Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million) Table 48. Asia-Pacific LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million) Table 49. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2016-2021) & (US$ Million) Table 50. Asia-Pacific LFA-based Cardiac Marker Market Size by Region (2022-2027) & (US$ Million) Table 51. Latin America LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 52. Latin America LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million) Table 53. Latin America LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million) Table 54. Latin America LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million) Table 55. Latin America LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million) Table 56. Latin America LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million) Table 57. Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2016-2021) (US$ Million) Table 58. Middle East & Africa LFA-based Cardiac Marker Market Size by Type (2022-2027) & (US$ Million) Table 59. Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2016-2021) (US$ Million) Table 60. Middle East & Africa LFA-based Cardiac Marker Market Size by Application (2022-2027) & (US$ Million) Table 61. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2016-2021) & (US$ Million) Table 62. Middle East & Africa LFA-based Cardiac Marker Market Size by Country (2022-2027) & (US$ Million) Table 63. Thermo Fisher Company Details Table 64. Thermo Fisher Business Overview Table 65. Thermo Fisher LFA-based Cardiac Marker Product Table 66. Thermo Fisher Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 67. Thermo Fisher Recent Development Table 68. Bio-Rad Laboratories Company Details Table 69. Bio-Rad Laboratories Business Overview Table 70. Bio-Rad Laboratories LFA-based Cardiac Marker Product Table 71. Bio-Rad Laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 72. Bio-Rad Laboratories Recent Development Table 73. Becton, Dickinson Company Details Table 74. Becton, Dickinson Business Overview Table 75. Becton, Dickinson LFA-based Cardiac Marker Product Table 76. Becton, Dickinson Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 77. Becton, Dickinson Recent Development Table 78. Roche Company Details Table 79. Roche Business Overview Table 80. Roche LFA-based Cardiac Marker Product Table 81. Roche Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 82. Roche Recent Development Table 83. Hologic Company Details Table 84. Hologic Business Overview Table 85. Hologic LFA-based Cardiac Marker Product Table 86. Hologic Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 87. Hologic Recent Development Table 88. Abbott Company Details Table 89. Abbott Business Overview Table 90. Abbott LFA-based Cardiac Marker Product Table 91. Abbott Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 92. Abbott Recent Development Table 93. Siemens Company Details Table 94. Siemens Business Overview Table 95. Siemens LFA-based Cardiac Marker Product Table 96. Siemens Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 97. Siemens Recent Development Table 98. Danaher Company Details Table 99. Danaher Business Overview Table 100. Danaher Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 101. Danaher Recent Development Table 102. Alere Company Details Table 103. Alere Business Overview Table 104. Alere LFA-based Cardiac Marker Product Table 105. Alere Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 106. Alere Recent Development Table 107. BioMérieux Company Details Table 108. BioMérieux Business Overview Table 109. BioMérieux LFA-based Cardiac Marker Product Table 110. BioMérieux Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 111. BioMérieux Recent Development Table 112. LSI Company Details Table 113. LSI Business Overview Table 114. LSI LFA-based Cardiac Marker Product Table 115. LSI Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 116. LSI Recent Development Table 117. Clinical Diagnostics Company Details Table 118. Clinical Diagnostics Business Overview Table 119. Clinical Diagnostics LFA-based Cardiac Marker Product Table 120. Clinical Diagnostics Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 121. Clinical Diagnostics Recent Development Table 122. Randox laboratories Company Details Table 123. Randox laboratories Business Overview Table 124. Randox laboratories LFA-based Cardiac Marker Product Table 125. Randox laboratories Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 126. Randox laboratories Recent Development Table 127. Wondfo Biotech Company Details Table 128. Wondfo Biotech Business Overview Table 129. Wondfo Biotech LFA-based Cardiac Marker Product Table 130. Wondfo Biotech Revenue in LFA-based Cardiac Marker Business (2016-2021) & (US$ Million) Table 131. Wondfo Biotech Recent Development Table 132. Research Programs/Design for This Report Table 133. Key Data Information from Secondary Sources Table 134. Key Data Information from Primary Sources List of Figures Figure 1. Global LFA-based Cardiac Marker Market Share by Type: 2020 VS 2027 Figure 2. Troponin Features Figure 3. CK-MB Features Figure 4. Myoglobin Features Figure 5. Others Features Figure 6. Global LFA-based Cardiac Marker Market Share by Application: 2020 VS 2027 Figure 7. Laboratory Testing Case Studies Figure 8. Point-of-care Testing Case Studies Figure 9. LFA-based Cardiac Marker Report Years Considered Figure 10. Global LFA-based Cardiac Marker Market Size (US$ Million), Year-over-Year: 2016-2027 Figure 11. Global LFA-based Cardiac Marker Market Size (US$ Million), 2016 VS 2021 VS 2027 Figure 12. Global LFA-based Cardiac Marker Market Share by Regions: 2020 VS 2027 Figure 13. Global LFA-based Cardiac Marker Market Share by Regions (2022-2027) Figure 14. Global LFA-based Cardiac Marker Market Share by Players in 2020 Figure 15. Global Top LFA-based Cardiac Marker Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in LFA-based Cardiac Marker as of 2020 Figure 16. The Top 10 and 5 Players Market Share by LFA-based Cardiac Marker Revenue in 2020 Figure 17. Global LFA-based Cardiac Marker Revenue Market Share by Type (2016-2021) Figure 18. Global LFA-based Cardiac Marker Revenue Market Share by Type (2022-2027) Figure 19. North America LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 20. North America LFA-based Cardiac Marker Market Share by Type (2016-2027) Figure 21. North America LFA-based Cardiac Marker Market Share by Application (2016-2027) Figure 22. North America LFA-based Cardiac Marker Market Share by Country (2016-2027) Figure 23. United States LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 24. Canada LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 25. Europe LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 26. Europe LFA-based Cardiac Marker Market Share by Type (2016-2027) Figure 27. Europe LFA-based Cardiac Marker Market Share by Application (2016-2027) Figure 28. Europe LFA-based Cardiac Marker Market Share by Country (2016-2027) Figure 29. Germany LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 30. France LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 31. U.K. LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 32. Italy LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 33. Russia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 34. Nordic LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 35. Asia-Pacific LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 36. Asia-Pacific LFA-based Cardiac Marker Market Share by Type (2016-2027) Figure 37. Asia-Pacific LFA-based Cardiac Marker Market Share by Application (2016-2027) Figure 38. Asia-Pacific LFA-based Cardiac Marker Market Share by Region (2016-2027) Figure 39. China LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 40. Japan LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 41. South Korea LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 42. Southeast Asia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 43. India LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 44. Australia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 45. Latin America LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 46. Latin America LFA-based Cardiac Marker Market Share by Type (2016-2027) Figure 47. Latin America LFA-based Cardiac Marker Market Share by Application (2016-2027) Figure 48. Latin America LFA-based Cardiac Marker Market Share by Country (2016-2027) Figure 49. Mexico LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 50. Brazil LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 51. Middle East & Africa LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 52. Middle East & Africa LFA-based Cardiac Marker Market Share by Type (2016-2027) Figure 53. Middle East & Africa LFA-based Cardiac Marker Market Share by Application (2016-2027) Figure 54. Middle East & Africa LFA-based Cardiac Marker Market Share by Country (2016-2027) Figure 55. Turkey LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 56. Saudi Arabia LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 57. UAE LFA-based Cardiac Marker Market Size YoY Growth (2016-2027) & (US$ Million) Figure 58. Thermo Fisher Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 59. Bio-Rad Laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 60. Becton, Dickinson Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 61. Roche Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 62. Hologic Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 63. Abbott Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 64. Siemens Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 65. Danaher Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 66. Alere Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 67. BioMérieux Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 68. LSI Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 69. Clinical Diagnostics Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 70. Randox laboratories Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 71. Wondfo Biotech Revenue Growth Rate in LFA-based Cardiac Marker Business (2016-2021) Figure 72. Bottom-up and Top-down Approaches for This Report Figure 73. Data Triangulation Figure 74. Key Executives Interviewed

Thermo Fisher Bio-Rad Laboratories Becton, Dickinson Roche Hologic Abbott Siemens Danaher Alere BioMérieux LSI Clinical Diagnostics Randox laboratories Wondfo Biotech